Your browser doesn't support javascript.
loading
How can I assess my patients with Parkinson's disease during a busy clinic day?
Cubo, Esther; Garcia-Bustillo, Alvaro; Calvo, Sara; Gámez-Leyva, Gonzalo; Simón-Vicente, Lucia; Rivadeneyra, Jessica; Miranda, Javier; Madrigal, Elisabet; Martínez-Martín, Pablo; Mir, Pablo; Santos-García, Diego.
Afiliação
  • Cubo E; Neurology Department, Hospital Universitario Burgos, Spain; University of Burgos, Spain. Electronic address: mcubo@saludcastillayleon.es.
  • Garcia-Bustillo A; Neurology Department, Hospital Universitario Burgos, Spain; University of Burgos, Spain.
  • Calvo S; Research Unit, Hospital Universitario Burgos, Spain.
  • Gámez-Leyva G; Neurology Department, Hospital Universitario Burgos, Spain.
  • Simón-Vicente L; University of Burgos, Spain; Research Unit, Hospital Universitario Burgos, Spain.
  • Rivadeneyra J; Research Unit, Hospital Universitario Burgos, Spain.
  • Miranda J; Neurology Department, Hospital Universitario Burgos, Spain.
  • Madrigal E; Neurology Department, Hospital Universitario Burgos, Spain.
  • Martínez-Martín P; CIBERNED (Centro de Investigación Biomédica en Red Enfermedades Neurodegenerativas), Spain.
  • Mir P; CIBERNED (Centro de Investigación Biomédica en Red Enfermedades Neurodegenerativas), Spain; Unidad de Trastornos Del Movimiento, Servicio de Neurología y Neurofisiología Clínica, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen Del Rocío/CSIC/Universidad de Sevilla, Seville, Spain.
  • Santos-García D; CHUAC, Complejo Hospitalario Universitario de A Coruña, A Coruña, Spain.
Parkinsonism Relat Disord ; 114: 105773, 2023 09.
Article em En | MEDLINE | ID: mdl-37607410
ABSTRACT

BACKGROUND:

The evaluation of motor impairment in Parkinson's disease (PD) is mainly assessed with the motor subdomain of the Unified Parkinson's Disease Rating scale (UPDRS part III) and, lately, with the MDS-UPDRS part III. To optimize efforts and special needs during specific circumstances in clinical practice, we sought to identify the most sensitive items to assess motor impairment in PD.

METHODS:

We included the COPPADIS-PD cohort and collected the UPDRS part III at baseline (V0), 12 months (V1), and 24 months (V2). Factor analysis and effect size using Cohen's d formula were performed in the Off and On states at V0, V1, and V2.

RESULTS:

We included 667 patients with PD, mean age of 62.59 ± 8.91 years, 410 (60.2%) males, with a median HY stage of 2.00 (1.00; 4.00) at baseline. Over time, the most discriminating items were postural stability and body bradykinesia ("arise from chair" and "gait") in the Off state, right and left upper extremity bradykinesia ("finger tap", "hand movements" and "prono/supination") in the On state. Body bradykinesia and right-left finger tapping were the items with the largest effect size (0.93, 0.84, 0.83, respectively) to assess motor improvement after receiving antiparkinsonian medications over time.

CONCLUSION:

Under specific circumstances, selecting a few items of the UPDRS part III, including postural stability, body bradykinesia, and upper extremity bradykinesia, could be used to create a quick clinical judgment of motor status and improvement in PD.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Parkinsonism Relat Disord Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Parkinsonism Relat Disord Ano de publicação: 2023 Tipo de documento: Article